Jonathan Freve
Director of Finance/CFO at GALECTO, INC.
Net worth: 8 028 $ as of 2024-04-29
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Hans Schambye | M | 59 | 13 years | |
| Garrett Winslow | M | 45 | 7 years | |
| Carl Samuel Goldfischer | M | 65 | 4 years | |
| Amit Munshi | M | 56 | 4 years | |
| Chau Khuong | M | 48 | 6 years | |
| David Shapiro | M | 69 | 4 years | |
| Patricia Zuccotti | F | 77 | 13 years | |
| David Mann | M | 85 | 13 years | |
| Søren Møller | M | 56 | 4 years | |
| Anne Prener | M | 66 | 3 years | |
| Lou Maroun | M | 74 | 13 years | |
| Jayson Dallas | M | 56 | 4 years | |
| Connor Teskey | M | 36 | 12 years | |
| Anders Pedersen | M | 64 | 4 years | |
| Jennifer Mazin | F | 51 | 10 years | |
| Jeffrey Blidner | M | 76 | 13 years | |
| Stephanie Oestreich | M | 50 | 2 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Ranjan Kalia | M | 63 | - | |
| Martin Driscoll | M | 65 | 5 years | |
| Lori Firmani | F | 51 | - | |
| Douglas J. Jensen | M | - | 13 years | |
| Pamela Klein | M | 63 | 1 years | |
| Scott Smith | M | 61 | 2 years | |
| Joseph deBethizy | M | 74 |
Roche Innovation Center Copenhagen A/S
 Roche Innovation Center Copenhagen A/S Pharmaceuticals: MajorHealth Technology Roche Innovation Center Copenhagen A/S discovers and develops drugs for the treatment of oncology, metabolic diseases, and infectious diseases. The firm manufactures a pipeline of drug candidates that act selectively on disease-related ribonucleic acid to provide patients with novel treatments for both rare and common diseases. It produces pre-clinical and clinical assets for the treatment of a range of diseases including oncology, metabolic diseases, and infectious diseases. The company was founded by Matts Lundwall and Mikael Ørum on January 1, 1998 and is headquartered in Horsholm, Denmark. | - |
| Danford F. Smith | M | 63 | 4 years | |
| Nick Goodman | M | - | - | |
| Kurt M. Eichler | M | 66 | 5 years | |
| Christiana Goh Bardon | M | 53 | 1 years | |
| Jonathan Bates | M | 64 | 10 years | |
| Al-Noor Ramji | M | 68 | 10 years | |
| Walter Wenninger | M | 86 |
Roche Innovation Center Copenhagen A/S
Roche Innovation Center Copenhagen A/S Pharmaceuticals: MajorHealth Technology Roche Innovation Center Copenhagen A/S discovers and develops drugs for the treatment of oncology, metabolic diseases, and infectious diseases. The firm manufactures a pipeline of drug candidates that act selectively on disease-related ribonucleic acid to provide patients with novel treatments for both rare and common diseases. It produces pre-clinical and clinical assets for the treatment of a range of diseases including oncology, metabolic diseases, and infectious diseases. The company was founded by Matts Lundwall and Mikael Ørum on January 1, 1998 and is headquartered in Horsholm, Denmark. | 8 years |
| Todd Brady | M | 52 | - | |
| Guy MacDonald | M | 65 | - | |
| John van Egmond | M | 74 | 8 years | |
| Timothy Clackson | M | 58 | - | |
| William O'Brien | M | 80 | 12 years | |
| Eleazar de Carvalho Filho | M | 66 | 9 years | |
| Samir Dhir | M | 53 | 12 years | |
| Praveen Purushotham | M | - | 10 years | |
| Sundararajan Narayanan | M | 50 | 13 years | |
| Neeraj Dutt | M | - | - | |
| Sreekanth Lapala | M | - | 8 years | |
| Kevin Leach | M | - | - | |
| Bertil Lindmark | M | 68 | 3 years | |
| Martinus Adrianus van Osch | M | - |
Roche Innovation Center Copenhagen A/S
Roche Innovation Center Copenhagen A/S Pharmaceuticals: MajorHealth Technology Roche Innovation Center Copenhagen A/S discovers and develops drugs for the treatment of oncology, metabolic diseases, and infectious diseases. The firm manufactures a pipeline of drug candidates that act selectively on disease-related ribonucleic acid to provide patients with novel treatments for both rare and common diseases. It produces pre-clinical and clinical assets for the treatment of a range of diseases including oncology, metabolic diseases, and infectious diseases. The company was founded by Matts Lundwall and Mikael Ørum on January 1, 1998 and is headquartered in Horsholm, Denmark. | - |
| Lars-Göran Josefsson | M | 73 | 7 years | |
| Charles A. Speicher | M | 65 | 8 years | |
| Santanu Paul | M | - | 5 years | |
| Claus Asbjørn Andersson | M | 56 |
Roche Innovation Center Copenhagen A/S
Roche Innovation Center Copenhagen A/S Pharmaceuticals: MajorHealth Technology Roche Innovation Center Copenhagen A/S discovers and develops drugs for the treatment of oncology, metabolic diseases, and infectious diseases. The firm manufactures a pipeline of drug candidates that act selectively on disease-related ribonucleic acid to provide patients with novel treatments for both rare and common diseases. It produces pre-clinical and clinical assets for the treatment of a range of diseases including oncology, metabolic diseases, and infectious diseases. The company was founded by Matts Lundwall and Mikael Ørum on January 1, 1998 and is headquartered in Horsholm, Denmark. | 4 years |
| Stephan Christgau | M | 60 | 1 years | |
| Beat Christoph Krähenmann | M | 66 |
Roche Innovation Center Copenhagen A/S
Roche Innovation Center Copenhagen A/S Pharmaceuticals: MajorHealth Technology Roche Innovation Center Copenhagen A/S discovers and develops drugs for the treatment of oncology, metabolic diseases, and infectious diseases. The firm manufactures a pipeline of drug candidates that act selectively on disease-related ribonucleic acid to provide patients with novel treatments for both rare and common diseases. It produces pre-clinical and clinical assets for the treatment of a range of diseases including oncology, metabolic diseases, and infectious diseases. The company was founded by Matts Lundwall and Mikael Ørum on January 1, 1998 and is headquartered in Horsholm, Denmark. | - |
| Edwin de Graaf | M | - |
Roche Innovation Center Copenhagen A/S
Roche Innovation Center Copenhagen A/S Pharmaceuticals: MajorHealth Technology Roche Innovation Center Copenhagen A/S discovers and develops drugs for the treatment of oncology, metabolic diseases, and infectious diseases. The firm manufactures a pipeline of drug candidates that act selectively on disease-related ribonucleic acid to provide patients with novel treatments for both rare and common diseases. It produces pre-clinical and clinical assets for the treatment of a range of diseases including oncology, metabolic diseases, and infectious diseases. The company was founded by Matts Lundwall and Mikael Ørum on January 1, 1998 and is headquartered in Horsholm, Denmark. | - |
| Gunnar Magnus Modee Persson | M | 64 | - | |
| Søren Knud Carlsen | M | 72 |
Roche Innovation Center Copenhagen A/S
Roche Innovation Center Copenhagen A/S Pharmaceuticals: MajorHealth Technology Roche Innovation Center Copenhagen A/S discovers and develops drugs for the treatment of oncology, metabolic diseases, and infectious diseases. The firm manufactures a pipeline of drug candidates that act selectively on disease-related ribonucleic acid to provide patients with novel treatments for both rare and common diseases. It produces pre-clinical and clinical assets for the treatment of a range of diseases including oncology, metabolic diseases, and infectious diseases. The company was founded by Matts Lundwall and Mikael Ørum on January 1, 1998 and is headquartered in Horsholm, Denmark. | - |
| Claus Tycho Bræstrup | M | 79 |
Roche Innovation Center Copenhagen A/S
Roche Innovation Center Copenhagen A/S Pharmaceuticals: MajorHealth Technology Roche Innovation Center Copenhagen A/S discovers and develops drugs for the treatment of oncology, metabolic diseases, and infectious diseases. The firm manufactures a pipeline of drug candidates that act selectively on disease-related ribonucleic acid to provide patients with novel treatments for both rare and common diseases. It produces pre-clinical and clinical assets for the treatment of a range of diseases including oncology, metabolic diseases, and infectious diseases. The company was founded by Matts Lundwall and Mikael Ørum on January 1, 1998 and is headquartered in Horsholm, Denmark. | - |
| Hari Thokalahalli Narasimha | M | - | 3 years | |
| Jakob Dynnes Hansen | M | 69 | - |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 39 | 68.42% |
| Bermuda | 10 | 17.54% |
| Denmark | 8 | 14.04% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Jonathan Freve
- Personal Network
